HSBC Holdings’s Relmada Therapeutics RLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-9,275
Closed -$247K 2939
2022
Q1
$247K Buy
+9,275
New +$247K ﹤0.01% 2510